Vivos Therapeutics, Inc Claimed Company
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is an innovative medical technology company focused on the development and commercialization of screening and treatment for obstructive sleep apnea (OSA). Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial anomalies and/or mild to moderate OSA. This revolutionary treatment is called the Vivos Method.
Combining technologies and protocols that alter the size, shape, and position of the tissues of the upper airway, the Vivos Method opens airway space and can significantly reduce or even eliminate the symptoms and conditions associated with mild to moderate OSA.
read more
HR or Marketing? Claim Your Free Employer Account
Vivos Therapeutics, Inc CEO & Leadership Team Ratings
R. Kirk Huntsman and the Vivos Therapeutics, Inc leadership team are scored an A+ by 2 employees placing it in the Top 5% of companies sized 51-200 Employees on Comparably. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.
Based on 6 ratings, the Leadership score of 92/100 combines employee feedback on their CEO (85/100), Manager (100/100), and Executive Team (90/100).
R. Kirk Huntsman Vivos Therapeutics, Inc CEO Rating
Top 5% Compared to other companies of similar size in DenverA+
85 / 100
R. Kirk Huntsman the CEO of Vivos Therapeutics, Inc received an average score of 85 from Vivos Therapeutics, Inc employees.Vivos Therapeutics, Inc Manager Rating
Top 5% Compared to other companies of similar size in DenverA+
100 / 100
Vivos Therapeutics, Inc Executive Team Rating
Top 5% Compared to other companies of similar size in DenverA+
90 / 100
×